Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Terminated 1Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 296Carcinoma, Hepatocellular 212Stomach Neoplasms 155Pancreatic Neoplasms 155Rectal Neoplasms 114Esophageal Neoplasms 84Colonic Neoplasms 78Esophageal Squamous Cell Carcinoma 51Cholangiocarcinoma 48Liver Neoplasms 46Biliary Tract Neoplasms 36Neoplasms 31Breast Neoplasms 31Neoplasm Metastasis 28Gastrointestinal Neoplasms 26Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 20Disease 18Prostatic Neoplasms 17Uterine Cervical Neoplasms 16Recurrence 16Ovarian Neoplasms 14Colorectal Neoplasms, Hereditary Nonpolyposis 13Endometrial Neoplasms 12Head and Neck Neoplasms 11Adenocarcinoma Of Esophagus 11Gallbladder Neoplasms 10Colonic Polyps 10Anus Neoplasms 10Melanoma 9

Interventions

Gemcitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Anophthalmia with pulmonary hypoplasia × Gastrointestinal × Clear all
NCT06361030 2024-04-11

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Anophthalmia with pulmonary hypoplasia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡